EP0904234B1 - Improved medical containers - Google Patents

Improved medical containers Download PDF

Info

Publication number
EP0904234B1
EP0904234B1 EP97921049A EP97921049A EP0904234B1 EP 0904234 B1 EP0904234 B1 EP 0904234B1 EP 97921049 A EP97921049 A EP 97921049A EP 97921049 A EP97921049 A EP 97921049A EP 0904234 B1 EP0904234 B1 EP 0904234B1
Authority
EP
European Patent Office
Prior art keywords
container
stopper
autoclavable
fluid
container opening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP97921049A
Other languages
German (de)
French (fr)
Other versions
EP0904234A1 (en
Inventor
Gunnar Andersson
Des Mulligan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi AB
Original Assignee
Fresenius Kabi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi AB filed Critical Fresenius Kabi AB
Priority to SI9730415T priority Critical patent/SI0904234T1/en
Publication of EP0904234A1 publication Critical patent/EP0904234A1/en
Application granted granted Critical
Publication of EP0904234B1 publication Critical patent/EP0904234B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers

Definitions

  • the present invention relates to an improved opening for medical containers, especially suitable for containers storing parenterally administerable fluids which preferably should be sterilized by steam after being finally assembled filled and sealed.
  • Flexible containers for storage of parenteral nutrients are conventionally provided with ports for filling and dispensing of the nutrients.
  • Tubular ports may be attached by means of welding when forming side seams, as performed in the International Patent Application WO 95/26177 (Fresenius AG).
  • Another manner of providing a flexible container with ports is disclosed in the above mentioned Swedish patent application 9601348-7, wherein a flexible polymer material is introduced in the form of sheets, to which a saddle formed port system comprising two separate ports is attached.
  • two holes are pressed in the sheet for the tubular ports, whereupon the saddle is welded to the sheet which is folded and welded to a bag shaped container by forming two side seams and a top seam.
  • the container may be filled through the saddle formed port, or preferably by one or more temporary ports in connection to the welded seams before it is sterilized.
  • Conventional saddle-formed port systems normally comprise an additive port for the introduction to the container, just before administration, of a complementary perishable fluid, such as a solution of vitamins to a stored parenteral nutrient. It will also comprise a dispensing port for establishing a fluid connection between the container and the patient in need of fluid therapy.
  • the ports are generally tube formed and often of a predetermined different size in order to clearly show their identity to the user .
  • the additive port is often sealed with a stopper made of latex rubber fitted in mouth of the port which can be penetrated by a needle.
  • the dispensing port is typically formed with a membrane of polypropylene which can be pierced with a spike connected to the infusion device.
  • the mouth of such a port is finally sealed before storage by a removable cap or a foil.
  • These ports have a drawback in that the small space between the stopper and the sealing cap or foil will not be reached by sterilizing steam which constitutes a risk for contamination in connection with the penetration.
  • the saddle-formed port systems have either been pre-sterilized by means of radiation before being assembled to the bags or alternatively a water droplet has been introduced in the small space to provide sterilizing vapor during the heat treatment.
  • US-A-4,230,231 and US-A-5,084,040 describe a container opening comprising a tubular sleeve-formed part having a resilient stopper inserted in its mouth and a sealing device covering the mouth.
  • the container opening is made of autoclavable polyolefinic material. The risk of also these container openings is that a small space between stopper and cap will not be properly sterilized by steam in a single process.
  • a specific object of the present invention is to provide a flexible bag-formed container for storage of parenteral fluids having a saddle-formed port system for introducing fluids to and dispensing fluids from the bag which is possible to sterilize in a single operation, and where all surfaces of the sealed opening which will be exposed to the fluid and fluid handling devices are correctly sterilized by steam.
  • a further specific object of the invention is to provide such a completely sterilizable bag-formed container with a saddle-formed port system which has a cheap environmental friendly construction that can be recycled in the same process without dismembering its parts before its disposal.
  • a still further specific object of the invention is to provide the saddle-formed port system of the container with openings which are possible to attach to a high number different connecting spikes.
  • the present invention is directed to container openings for fluid communication with a container for storing medical fluids, especially for parenteral administration.
  • the container opening comprises a tubular sleeve-formed part with a resilient and pierceable stopper inserted in its mouth and a sealing device covering said mouth and stopper.
  • the tubular sleeve-formed part, the stopper, and the sealing device contain, at least to a substantial amount, the same polyolefinic material, so they can be recycled with same process in a recycling plant without being dismembered and separately collected after use.
  • a sealed container opening according to the present invention It is a characteristic feature of a sealed container opening according to the present invention that it can be heat sterilized by steam in a single process while all its parts, that will be exposed to, or come in contact with, either with the fluid directly or devices used for handling or transferring the fluid are sterilized by means of direct contact with steam transferred to said parts during the autoclavation.
  • the inventive container openings are provided with a covering sealing device in the form of a peelable foil.
  • This foil can be penetrated by steam during in the autoclave, so the upper pierceable surface beneath the foil and the space between the foil and the stopper is sterilized by direct contact with steam.
  • the stopper besides the polyolefinic material, contains a thermoplastic elastomer.
  • Preferred polyolefinic materials, according to the invention are polypropylene and/or polyethene.
  • the present invention is also directed to a container having at least one aforedescribed opening comprising a tubular sleeve-formed part closed with a resilient, pierceable stopper and said sealing device, wherein all parts of the container and its orifice essentially consist of the same polyolefin.
  • the container can either be in the form of a flexible bag having at least one of said orifices or in a conventional bottle formed container of a polyolefin based material with a sealed orifice having said features.
  • Fig. 1 shows only for illustrative purpose a saddle-formed port system with two ports. This system does not fall within the scope of the appended claims.
  • Fig. 2 is an enlargement of a steam transporting axial slit between the stopper and the tubular sleeve wall in one of the ports according to Fig. 1.
  • Fig. 3 shows an embodiment of an opening according to the present invention.
  • Fig. 4 shows a saddle-formed port system having the opening of Fig. 3 attached.
  • Fig. 1 shows a side view of a saddle-port system 30 with two openings for fluid communication with a container (not shown) constituted by the ports 20 and 20' which are of somewhat different size for easily identifying the dispensing and additive port, respectively.
  • Both ports have sealed openings and are largely identical and consist of a generally cylindrical, tubular sleeves 22, 22' which preferably have slightly beveled part 23, 23' of a shape designed to fit various fluid transfer devices, such as a conventional spike-formed connections to an infusion device. It is particularly preferred to have such a shape that fits spikes according to the conventional ISO-standard.
  • a cylindrical resilient and pierceable stopper 24 is positioned in the mouth part 21 of the orifices by means of an insert device 25 which rests on an annular shelf 26.
  • the stopper is made of a resilient thermoplastic elastomer and is designed to fit snugly and sealingly in the mouth. It is conceivable to find other suitable designs of the insert device and the annular shelf extended around the inner periphery of the tubular sleeves.
  • the ports can be provided with a fingergrip portion 27 to give the user a more comfortable stability when inserting devices for fluid transfer into the port.
  • the mouth of the opening is sealed with a cap formed sealing device 10 which is provided with a flange 11 fitted over the edge of the mouth.
  • the contact surface between the mouth and the cap formed sealing device can be welded together by, for example ultrasonic welding.
  • the cap formed sealing device can also be provided with a preformed rupture line (not shown) which preferably is circular and will burst when it is twisted by the user to provide a round aperture, through which a needle or spike can penetrate the stopper and establish fluid communication with the container.
  • annular slit 41 between the peripheral surface of stopper and the inner peripheral wall of the tubular sleeve of the orifice.
  • the slit 41 opens for transportation of steam from the interior of the container to the closed space 40 during the autoclavation of the container.
  • Such an axial slit is formed when the tubular sleeve expands more in a radial direction than the stopper during the heat treatment in the autoclave.
  • the slit closes because of a comparable contraction of the stopper and the sleeve and a weak seal is formed in their contact surface.
  • the stopper contains a certain amount of a thermoplastic elastomer, such as a dispersed EPDM-rubber or SEBS (styrene-ethylene-butadien-styrene copolymer), so the stopper can exert a balancing pressure when tubular sleeve expands and contracts during the autoclavation process.
  • a high compatibility between these parts are also required, because molecules must be exchanged in the contact surface of said parts, in order to form a weak seal.
  • Both the stopper and the tubular orifice sleeve should therefore contain the same polyolefinic material, in order to obtain such a molecular compatibility.
  • This requirement that must also be set on the entire port system for enabling it to be recycled together with the rest of the container.
  • the port system must, consequently, also be compatible with the material of the flexible container, so it can successfully be attached to it by means of welding during the assembly.
  • the stopper must have certain resilience to meet the requirements to obtain a weak welding, as well as being resealable, so it can be penetrated several times and maintain the integrity of the container. It is also a requirement that the stopper material shall have a certain friction against the connection spike to prevent the spike to be unintentionally displaced from the stopper and to provide a sealing connection with a high number of different types of connecting spikes existing on the market.
  • a suitable material for the stopper is a polyolefin polymer which contains a thermoplastic elastomer.
  • the same polyolefin must be present, both in the remaining parts of the port system and in the container.
  • Suitable polyolefin materials are polyetylenes or polypropylene, their mixtures and copolymers of various medical grades. It has been shown in the present invention that it is surprisingly advantageous to have a high amount of polypropylene in the port system compatible with a polypropylene containing material in the containers.
  • the stopper it is especially preferred to select materials of polypropylene containing a certain amount of a thermoplastic elastomer like Dynaflex® from GLS Corp. comprising polypropylene and SEBS.
  • a thermoplastic elastomer like Dynaflex® from GLS Corp. comprising polypropylene and SEBS.
  • other polypropylene based materials having comparable characteristics can be used in the present invention, such as those having dispersed particles of EPDM-rubber in the matrix like Santoprene® from Monsanto.
  • a stopper made of such a material will also solve the problem with particles torn away as a result of its penetration and it has a high resealing capacity after a penetration.
  • the material of the remaining saddle-formed port system shall preferably be compatible with the material of the infusion bag in order enable a suitable attachment, for example by means of welding. Both materials shall preferably contain the same polyolefinic material so they are capable of being recycled in the process and so a separate collection procedure is avoided.
  • a suitable material for the bag formed infusion container is based on polyolefines, such as polyethylene or polypropylene, their mixture and copolymers.
  • a preferred material is Excel® from McGaw Inc., generally described in the European patent 0228919. Excel® has a multilayered structure substantially comprising:
  • the saddle formed port system suitable contains polypropylene and preferably consists of a mixture of polypropylene and Kraton® which is weldable to the inner layer of the Excel® film. Suitable mixtures are in range of about 80 to 40% polypropylene and 20 to 60% Kraton®.
  • the polypropylene is of homogenous interpenetrating polymer network (IPN) quality, capable of forming weak seals at about 105 to 120°C, preferably at about 117°C and a permanent welding at about 160°C.
  • IPN interpenetrating polymer network
  • FIG. 3 An embodiment of a sealed opening to a medical container, according to the invention, is demonstrated in Fig. 3.
  • This opening is suitable in the previously discussed saddle-formed port system, has a generally cylindrical part 22A with a mouth 21A.
  • a resilient and pierceable stopper 24A is sealingly positioned in the mouth and rests on the annular shelf 26A formed in said sleeve 22A.
  • the stopper 24A is made of a resilient pierceable material, suitably a polyolefin containing a certain amount of a thermoplastic elastomer and preferably Dynaflex® or a comparable material as disclosed above, while the other parts of the orifice preferably are made of polypropylene with mixtures of Kraton®, as also disclosed above.
  • the opening is sealed before sterilization by a peelable foil 12A which is sealingly fitted over an annular outwardly extended protrusion 28A of the mouth 21A.
  • steam must the transferred also to the upper surface 40A of the pierceable stopper 24A which shall be penetrated by a needle or a spike.
  • a transfer of steam therefore must be arranged through the peelable foil in the autoclave, while the foil also must be capable of maintaining sterile conditions and prevent airborne or contact contamination of the surface 40A during the subsequent storage.
  • the material of the peelable foil must therefore be selected among steam permeable, but heat resistant materials which otherwise can form an effective sealing barrier for contaminating agents. Suitable materials are found among spun polyolefins, such as Tyvek® from DuPont and among certain qualities of lacquered papers.
  • this type of container opening is preferably connected to the mouth part of the generally cylindrically formed sleeves of a port of a saddle formed port system.
  • the outer peripheral surface of the cylindrical part 22A can be provided with an annular protrusion 29 which is intended to fit in a corresponding annular recess 29' provided in the inner peripheral surface of the sleeve formed port.
  • the openings are manufactured in a process wherein the Dynaflex® is injected into a pre-shaped cylindrical opening by means of two-color mold injection machine, whereupon the foil is assembled in a separate process.
  • the foil 12A When using such a container opening for fluid transfer, the foil 12A will be removed by a simple peeling motion to expose the sterile upper pierceable surface 40A of the stopper which can immediately be pierced by a conventional connection spike or a comparable device for establishing fluid connection without a risk for contamination.
  • the described sealed container openings and the saddle-formed port systems including them will, for many practical applications eliminate the use of a secondary, outer pouch wrapped over the bag-formed container during storage for standard solutions and other parenteral solutions, even if certain oxygen sensitive products like amino acids and lipid emulsion will require additional protective measures.
  • inventive container opening not only shall be regarded as limited in use to saddle formed port systems connected to flexible bag-formed containers. It is equally useful as a part of a bottle shaped more rigid polymer container containing sensitive medical fluids which require autoclavation before storage.

Abstract

A sealed container opening, intended for fluid communication with a container for storing medical fluids, comprising a tubular sleeve-formed part (22, 22A) having a resilient pierceable stopper (24, 24A) inserted in its mouth (21, 21A) and a covering sealing device (10, 10A). The sealed container opening contains the same autoclavable polyolefinic material as the container. All parts of said container opening, exposed to the fluid or fluid handling devices are sterilized in a signal process by means of steam transferred to these parts during its autoclavation. Saddle formed port systems attachable to a flexible container are also disclosed.

Description

Field of invention
The present invention relates to an improved opening for medical containers, especially suitable for containers storing parenterally administerable fluids which preferably should be sterilized by steam after being finally assembled filled and sealed.
Background of the invention
For manufacturers of parenteral fluids who wish to replace the traditional glass containers, it has been a highly demanding problem to find a polymeric material capable of withstanding autoclavation and yet be able to meet the often rigorous requirements set on its oxygen barrier and water vapor barrier capacities. Especially when sensitive fluids for use in parenteral nutrition, such as lipid emulsions containing long chain polyunsaturated fatty acids, amino acid solutions and carbohydrates shall be heat sterilized and stored for a long time, problems with oxygen induced degradation and incompatibility with the polymeric material, might lead to the appearance of potentially hazardous products. A solution to the problem of finding a suitable storage system comprising a flexible container filled with parenteral nutrients to replace glass bottles is demonstrated in the as yet unpublished Swedish patent application 9601348-7.
When manufacturing different types of containers of polymeric materials for storing parenterally administerable fluids, it has been a considerable problem to provide a suitable degree of sterility for all the parts of the container. It would be highly desirable, for reasons of safety for the patients, for the convenience of hospital personal and for economical reasons to achieve and maintain a suitably high degree of sterility by means of a single steam sterilization process (i.e. autoclavation) which is performed after the container has been finally assembled, filled and sealed.
Flexible containers for storage of parenteral nutrients are conventionally provided with ports for filling and dispensing of the nutrients. Tubular ports may be attached by means of welding when forming side seams, as performed in the International Patent Application WO 95/26177 (Fresenius AG). Another manner of providing a flexible container with ports is disclosed in the above mentioned Swedish patent application 9601348-7, wherein a flexible polymer material is introduced in the form of sheets, to which a saddle formed port system comprising two separate ports is attached. When manufacturing such a container two holes are pressed in the sheet for the tubular ports, whereupon the saddle is welded to the sheet which is folded and welded to a bag shaped container by forming two side seams and a top seam. The container may be filled through the saddle formed port, or preferably by one or more temporary ports in connection to the welded seams before it is sterilized.
Conventional saddle-formed port systems normally comprise an additive port for the introduction to the container, just before administration, of a complementary perishable fluid, such as a solution of vitamins to a stored parenteral nutrient. It will also comprise a dispensing port for establishing a fluid connection between the container and the patient in need of fluid therapy. The ports are generally tube formed and often of a predetermined different size in order to clearly show their identity to the user .
The additive port is often sealed with a stopper made of latex rubber fitted in mouth of the port which can be penetrated by a needle. The dispensing port is typically formed with a membrane of polypropylene which can be pierced with a spike connected to the infusion device. The mouth of such a port is finally sealed before storage by a removable cap or a foil. These ports have a drawback in that the small space between the stopper and the sealing cap or foil will not be reached by sterilizing steam which constitutes a risk for contamination in connection with the penetration. To solve this problem, the saddle-formed port systems have either been pre-sterilized by means of radiation before being assembled to the bags or alternatively a water droplet has been introduced in the small space to provide sterilizing vapor during the heat treatment. Both these solutions are unsatisfying, since they require either an extra sterilization routine by radiation which often might deteriorate the quality of polymeric materials or an extra water droplet adding routine. Whenever using this type of containers, the handling personnel at the hospitals are instructed to, as an extra safety routine, wipe the latex rubber with a disinfectant before piercing it with a needle connected to an infusion tubing.
The same problem is also present with the type of plastic bottle formed containers made with a "blow-fill-seal" method, as described in the Swedish patent application 9303123-5. This type of bottles are sealed by a resilient stopper and a cap at the top of the bottle and finally sealed in the autoclave with a weak seal between the stopper and the inner surface of the container neck. The small space between the stopper and the cap will not be properly sterilized by steam unless a water droplet is introduced in a separate process. An incorrectly sterilized pierceable surface means a risk for contamination, especially when the containers are aimed for storage of several dosages and several collections of fluid will be made by piercing the stopper with a needle.
It would also be highly desirable to be able to recycle also a bag-formed container with an attached saddle-formed port system without a laborious dismembering and collection-of different materials in separate processes, as being made possible with the containers, according to the mentioned the Swedish patent application 9303123-5. The frequently used resilient latex stopper of the ports must be individually collected from used bags before they can be recycled. The presence of any latex stoppers will effectively spoil a recycling process of polypropylene based bags. It would also be advantageous to benefit from the advantage of introducing sealing weak weldings with the final heat sterilization, as obtained between the container body or the cap and elastomeric sealing device in the mentioned Swedish patent application 9303123-5.
It would also be desirable to provide a saddle formed port system having ports which fit to high number of spike connections without leakage so they are compatible with a large number of infusion sets existing on the market. Especially dispensing ports sealed with a polypropylene membrane, will often leak and are not sufficiently resealable after being pierced, while latex stoppers in addition ports have a drawbavk by their tendency to be unintentionally displaced from the mouth of the port. This type of sealing devices might also cause problems due to particles torn off when being penetrated.
US-A-4,230,231 and US-A-5,084,040 describe a container opening comprising a tubular sleeve-formed part having a resilient stopper inserted in its mouth and a sealing device covering the mouth. The container opening is made of autoclavable polyolefinic material. The risk of also these container openings is that a small space between stopper and cap will not be properly sterilized by steam in a single process.
According to the present invention it is intended to provide pierceable openings for medical containers which can overcome the above mentioned problems both in saddle port systems for bag formed containers and other types of containers.
It is an object of the invention to provide a sealed opening for a medical container which is capable of being correctly sterilized by steam in all parts exposed to the fluid and fluid handling devices.
It is another object of the invention to provide a medical package for parenterally administerable fluids where all parts exposed to the fluids or to fluid transferring devices are correctly sterilized in a single operation after it has been finally assembled and filled.
A specific object of the present invention is to provide a flexible bag-formed container for storage of parenteral fluids having a saddle-formed port system for introducing fluids to and dispensing fluids from the bag which is possible to sterilize in a single operation, and where all surfaces of the sealed opening which will be exposed to the fluid and fluid handling devices are correctly sterilized by steam.
A further specific object of the invention is to provide such a completely sterilizable bag-formed container with a saddle-formed port system which has a cheap environmental friendly construction that can be recycled in the same process without dismembering its parts before its disposal.
A still further specific object of the invention is to provide the saddle-formed port system of the container with openings which are possible to attach to a high number different connecting spikes.
These objects of the invention will be attained by the subject-matters disclosed in the appended claims. The invention as disclosed in the following part will also provide a solution to problems stated above.
Description of the invention
The present invention is directed to container openings for fluid communication with a container for storing medical fluids, especially for parenteral administration. The container opening comprises a tubular sleeve-formed part with a resilient and pierceable stopper inserted in its mouth and a sealing device covering said mouth and stopper. The tubular sleeve-formed part, the stopper, and the sealing device contain, at least to a substantial amount, the same polyolefinic material, so they can be recycled with same process in a recycling plant without being dismembered and separately collected after use. It is a characteristic feature of a sealed container opening according to the present invention that it can be heat sterilized by steam in a single process while all its parts, that will be exposed to, or come in contact with, either with the fluid directly or devices used for handling or transferring the fluid are sterilized by means of direct contact with steam transferred to said parts during the autoclavation.
The inventive container openings are provided with a covering sealing device in the form of a peelable foil. This foil can be penetrated by steam during in the autoclave, so the upper pierceable surface beneath the foil and the space between the foil and the stopper is sterilized by direct contact with steam.
It is preferred, according to the invention, that the stopper, besides the polyolefinic material, contains a thermoplastic elastomer. Preferred polyolefinic materials, according to the invention are polypropylene and/or polyethene.
The present invention is also directed to a container having at least one aforedescribed opening comprising a tubular sleeve-formed part closed with a resilient, pierceable stopper and said sealing device, wherein all parts of the container and its orifice essentially consist of the same polyolefin. The container can either be in the form of a flexible bag having at least one of said orifices or in a conventional bottle formed container of a polyolefin based material with a sealed orifice having said features.
Detailed description of the invention
Fig. 1 shows only for illustrative purpose a saddle-formed port system with two ports. This system does not fall within the scope of the appended claims.
Fig. 2 is an enlargement of a steam transporting axial slit between the stopper and the tubular sleeve wall in one of the ports according to Fig. 1.
Fig. 3 shows an embodiment of an opening according to the present invention.
Fig. 4 shows a saddle-formed port system having the opening of Fig. 3 attached.
Fig. 1, shows a side view of a saddle-port system 30 with two openings for fluid communication with a container (not shown) constituted by the ports 20 and 20' which are of somewhat different size for easily identifying the dispensing and additive port, respectively. Both ports have sealed openings and are largely identical and consist of a generally cylindrical, tubular sleeves 22, 22' which preferably have slightly beveled part 23, 23' of a shape designed to fit various fluid transfer devices, such as a conventional spike-formed connections to an infusion device. It is particularly preferred to have such a shape that fits spikes according to the conventional ISO-standard.
A cylindrical resilient and pierceable stopper 24 is positioned in the mouth part 21 of the orifices by means of an insert device 25 which rests on an annular shelf 26. The stopper is made of a resilient thermoplastic elastomer and is designed to fit snugly and sealingly in the mouth. It is conceivable to find other suitable designs of the insert device and the annular shelf extended around the inner periphery of the tubular sleeves. The ports can be provided with a fingergrip portion 27 to give the user a more comfortable stability when inserting devices for fluid transfer into the port. The mouth of the opening is sealed with a cap formed sealing device 10 which is provided with a flange 11 fitted over the edge of the mouth. To obtain a safe sealing against the environment, the contact surface between the mouth and the cap formed sealing device can be welded together by, for example ultrasonic welding. The cap formed sealing device can also be provided with a preformed rupture line (not shown) which preferably is circular and will burst when it is twisted by the user to provide a round aperture, through which a needle or spike can penetrate the stopper and establish fluid communication with the container.
As best demonstrated in Fig. 2, there is a small closed space 40 extended between the cap formed sealing device and the upper face of the stopper which might never be reached by sterilizing steam from the inside of the container during the autoclavation process. As a result, the surface penetrated by a needle or a connecting spike might be contaminated due to an unsatisfying sterilization which at worst case will waste the fluids of the container and be hazardous for the patient.
This problem is solved by the temporary formation of an axially extended annular slit 41 between the peripheral surface of stopper and the inner peripheral wall of the tubular sleeve of the orifice. The slit 41 opens for transportation of steam from the interior of the container to the closed space 40 during the autoclavation of the container. Such an axial slit is formed when the tubular sleeve expands more in a radial direction than the stopper during the heat treatment in the autoclave. When the container subsequently is cooled in the autoclave, the slit closes because of a comparable contraction of the stopper and the sleeve and a weak seal is formed in their contact surface.
The formation of a slit and the subsequent formation of a weak seal in the autoclave requires a careful selection of polymeric materials. To successfully obtain weak seals, it is important that the stopper contains a certain amount of a thermoplastic elastomer, such as a dispersed EPDM-rubber or SEBS (styrene-ethylene-butadien-styrene copolymer), so the stopper can exert a balancing pressure when tubular sleeve expands and contracts during the autoclavation process. A high compatibility between these parts are also required, because molecules must be exchanged in the contact surface of said parts, in order to form a weak seal. Both the stopper and the tubular orifice sleeve, should therefore contain the same polyolefinic material, in order to obtain such a molecular compatibility. This requirement that must also be set on the entire port system for enabling it to be recycled together with the rest of the container. The port system must, consequently, also be compatible with the material of the flexible container, so it can successfully be attached to it by means of welding during the assembly. Moreover, the stopper must have certain resilience to meet the requirements to obtain a weak welding, as well as being resealable, so it can be penetrated several times and maintain the integrity of the container. It is also a requirement that the stopper material shall have a certain friction against the connection spike to prevent the spike to be unintentionally displaced from the stopper and to provide a sealing connection with a high number of different types of connecting spikes existing on the market.
A suitable material for the stopper is a polyolefin polymer which contains a thermoplastic elastomer. The same polyolefin must be present, both in the remaining parts of the port system and in the container. Suitable polyolefin materials are polyetylenes or polypropylene, their mixtures and copolymers of various medical grades. It has been shown in the present invention that it is surprisingly advantageous to have a high amount of polypropylene in the port system compatible with a polypropylene containing material in the containers.
For the stopper it is especially preferred to select materials of polypropylene containing a certain amount of a thermoplastic elastomer like Dynaflex® from GLS Corp. comprising polypropylene and SEBS. However other polypropylene based materials having comparable characteristics can be used in the present invention, such as those having dispersed particles of EPDM-rubber in the matrix like Santoprene® from Monsanto. A stopper made of such a material will also solve the problem with particles torn away as a result of its penetration and it has a high resealing capacity after a penetration.
The material of the remaining saddle-formed port system shall preferably be compatible with the material of the infusion bag in order enable a suitable attachment, for example by means of welding. Both materials shall preferably contain the same polyolefinic material so they are capable of being recycled in the process and so a separate collection procedure is avoided. A suitable material for the bag formed infusion container is based on polyolefines, such as polyethylene or polypropylene, their mixture and copolymers. A preferred material is Excel® from McGaw Inc., generally described in the European patent 0228919.
Excel® has a multilayered structure substantially comprising:
  • a) an inner, sealant layer facing the medical fluid consisting of a mixture of a polyethylene/polypropylene copolymer (FINA Dypro Z 9450) and Kraton® G1652 from Shell (a styrene/ethylene/butadien/styrene copolymer);
  • b) a middle, tie layer of pure Kraton® G1652; and
  • c) an outer, release layer of Ecdel® 9965 (or 9566 or 9967) from Eastman Kodak & Co. which is a cycloaliphatic thermoplastic copolyester (a copoly(ester ether), a condensation product of the trans isomer of 1,4-dimethyl-cyclohexanedicarboxylate, of cyclohexanedimethanol and hydroxyterminated polytetramethylene glycol).
  • When using Excel® as the material for the bag formed container, the saddle formed port system suitable contains polypropylene and preferably consists of a mixture of polypropylene and Kraton® which is weldable to the inner layer of the Excel® film. Suitable mixtures are in range of about 80 to 40% polypropylene and 20 to 60% Kraton®. The polypropylene is of homogenous interpenetrating polymer network (IPN) quality, capable of forming weak seals at about 105 to 120°C, preferably at about 117°C and a permanent welding at about 160°C. However, the skilled person will have no difficulty in finding appropriate compositions of polypropylene and thermoplastic elastomer for the inventive port system and its constituents given the provisions set out above.
    An embodiment of a sealed opening to a medical container, according to the invention, is demonstrated in Fig. 3. This opening is suitable in the previously discussed saddle-formed port system, has a generally cylindrical part 22A with a mouth 21A. A resilient and pierceable stopper 24A is sealingly positioned in the mouth and rests on the annular shelf 26A formed in said sleeve 22A. The stopper 24A is made of a resilient pierceable material, suitably a polyolefin containing a certain amount of a thermoplastic elastomer and preferably Dynaflex® or a comparable material as disclosed above, while the other parts of the orifice preferably are made of polypropylene with mixtures of Kraton®, as also disclosed above. The opening is sealed before sterilization by a peelable foil 12A which is sealingly fitted over an annular outwardly extended protrusion 28A of the mouth 21A. In order to be able to correctly steam sterilize all parts of the orifice including the connected filled container, steam must the transferred also to the upper surface 40A of the pierceable stopper 24A which shall be penetrated by a needle or a spike. A transfer of steam therefore must be arranged through the peelable foil in the autoclave, while the foil also must be capable of maintaining sterile conditions and prevent airborne or contact contamination of the surface 40A during the subsequent storage. The material of the peelable foil must therefore be selected among steam permeable, but heat resistant materials which otherwise can form an effective sealing barrier for contaminating agents. Suitable materials are found among spun polyolefins, such as Tyvek® from DuPont and among certain qualities of lacquered papers.
    As demonstrated in Fig. 4, this type of container opening is preferably connected to the mouth part of the generally cylindrically formed sleeves of a port of a saddle formed port system. To facilitate the connection to the sleeves, the outer peripheral surface of the cylindrical part 22A can be provided with an annular protrusion 29 which is intended to fit in a corresponding annular recess 29' provided in the inner peripheral surface of the sleeve formed port. These features will also enable the container opening to be safely fixed to the sleeve during the handling, in order to avoid it to be unintentionally dismembered when removing a spike or a needle penetrating the stopper.
    The openings are manufactured in a process wherein the Dynaflex® is injected into a pre-shaped cylindrical opening by means of two-color mold injection machine, whereupon the foil is assembled in a separate process.
    When using such a container opening for fluid transfer, the foil 12A will be removed by a simple peeling motion to expose the sterile upper pierceable surface 40A of the stopper which can immediately be pierced by a conventional connection spike or a comparable device for establishing fluid connection without a risk for contamination.
    Besides the advantages stated above, the described sealed container openings and the saddle-formed port systems including them will, for many practical applications eliminate the use of a secondary, outer pouch wrapped over the bag-formed container during storage for standard solutions and other parenteral solutions, even if certain oxygen sensitive products like amino acids and lipid emulsion will require additional protective measures.
    It is also to be understood that the inventive container opening not only shall be regarded as limited in use to saddle formed port systems connected to flexible bag-formed containers. It is equally useful as a part of a bottle shaped more rigid polymer container containing sensitive medical fluids which require autoclavation before storage.

    Claims (7)

    1. A sealed container opening, intended for fluid communication with a container for storing medical fluids, comprising a tubular sleeve-formed part (22A) having a resilient pierceable stopper (24A) inserted in its mouth (21A) and a covering sealing device (10A), wherein said container opening contains an autoclavable polyolefinic material, characterized in that said covering sealing device is in the form of a peelable foil (12A) capable of being penetrated by sterilizing steam in order to sterilize the space between said foil and the stopper (24A).
    2. A container opening according to claim 1 characterized in that the polymeric material is polypropylene of polyethene, their mixtures or copolymers.
    3. A container opening according to claims 1 or 2 characterized in that the stopper (24A) further comprises a thermoplastic elastomer.
    4. An autoclavable container for storage of medical fluids having at least one container opening according to any of claims 1 to 3, wherein said container contains the same autoclavable polyolefinic material as the container opening.
    5. An autoclavable container according to claim 4 having a flexible container body made of a polyolefin containing mulitlayered material, wherein all parts of the container essentially consist of the same polyolefin.
    6. An autoclavable container according to claim 5, wherein said polyolefin is polypropylene.
    7. An autoclavable container comprising a saddle-formed port system having at least one of said container openings according to any of claims 1 to 3 for introducing an additional fluid to be mixed with said medical fluid and at least one of said container openings according to any of claims 1 to 3 connectable to a fluid transferring device.
    EP97921049A 1996-04-23 1997-04-23 Improved medical containers Expired - Lifetime EP0904234B1 (en)

    Priority Applications (1)

    Application Number Priority Date Filing Date Title
    SI9730415T SI0904234T1 (en) 1996-04-23 1997-04-23 Improved medical containers

    Applications Claiming Priority (3)

    Application Number Priority Date Filing Date Title
    SE9601540A SE9601540D0 (en) 1996-04-23 1996-04-23 Improved medical containers
    SE9601540 1996-04-23
    PCT/SE1997/000682 WO1997039952A1 (en) 1996-04-23 1997-04-23 Improved medical containers

    Publications (2)

    Publication Number Publication Date
    EP0904234A1 EP0904234A1 (en) 1999-03-31
    EP0904234B1 true EP0904234B1 (en) 2002-08-28

    Family

    ID=20402307

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP97921049A Expired - Lifetime EP0904234B1 (en) 1996-04-23 1997-04-23 Improved medical containers

    Country Status (13)

    Country Link
    EP (1) EP0904234B1 (en)
    JP (1) JP2000508993A (en)
    AT (1) ATE222871T1 (en)
    CA (1) CA2251267C (en)
    DE (1) DE69714992T2 (en)
    DK (1) DK0904234T3 (en)
    ES (1) ES2183165T3 (en)
    NO (1) NO318853B1 (en)
    NZ (1) NZ332178A (en)
    PT (1) PT904234E (en)
    SE (1) SE9601540D0 (en)
    WO (1) WO1997039952A1 (en)
    ZA (1) ZA973434B (en)

    Families Citing this family (10)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    SE9700597D0 (en) * 1997-02-20 1997-02-20 Pharmacia & Upjohn Ab Method of manufacturing pharmaceutical articles
    US6720044B2 (en) 1997-02-20 2004-04-13 Pharmacia Ab Polyolefinic closures comprising penetrable plugs and annular channels
    DE10313760B3 (en) * 2003-03-27 2004-06-03 Fresenius Kabi Deutschland Gmbh Connector for a bag containing medical fluids, for e.g. transfusion/infusion, has a connector with a clamp section integrated into the package by an expanded base and without a connection tube
    JP4060247B2 (en) * 2003-07-14 2008-03-12 株式会社大塚製薬工場 Mouth member for drug container
    JP4575084B2 (en) * 2003-08-22 2010-11-04 テルモ株式会社 Infusion container and method for producing infusion container
    KR100799716B1 (en) 2006-12-19 2008-02-01 박종현 A seal-cap unit and a sterilized container with seal-cap unit
    CA2804814C (en) * 2010-07-16 2015-11-10 Stevanato Group International A.S. Manufacturing process for packing of injectables
    JP6038658B2 (en) * 2011-02-04 2016-12-07 テルモ株式会社 Drug storage container
    WO2013058373A1 (en) * 2011-10-19 2013-04-25 ラジエ工業株式会社 Method for preventing deterioration of protein, and method for producing protein
    WO2013084791A1 (en) * 2011-12-05 2013-06-13 テルモ株式会社 Gasket storage container

    Citations (1)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US5084040A (en) * 1990-01-25 1992-01-28 The West Company, Incorporated Lyophilization device

    Family Cites Families (3)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US4230231A (en) * 1979-04-16 1980-10-28 Coulter Electronics, Inc. Closure cap
    US4297316A (en) * 1980-01-07 1981-10-27 Baxter Travenol Laboratories, Inc. Maintaining the dimensional integrity of thermoplastic tubing ends for receiving a luer
    SE501925C2 (en) * 1993-09-24 1995-06-19 Kabi Pharmacia Ab Containers for medical fluids and procedures for their sealing

    Patent Citations (1)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US5084040A (en) * 1990-01-25 1992-01-28 The West Company, Incorporated Lyophilization device

    Also Published As

    Publication number Publication date
    EP0904234A1 (en) 1999-03-31
    ATE222871T1 (en) 2002-09-15
    JP2000508993A (en) 2000-07-18
    NZ332178A (en) 2000-01-28
    SE9601540D0 (en) 1996-04-23
    ES2183165T3 (en) 2003-03-16
    CA2251267C (en) 2005-10-11
    DE69714992T2 (en) 2003-01-02
    WO1997039952A1 (en) 1997-10-30
    AU2719797A (en) 1997-11-12
    DK0904234T3 (en) 2002-12-30
    CA2251267A1 (en) 1997-10-30
    NO318853B1 (en) 2005-05-18
    AU715663B2 (en) 2000-02-10
    ZA973434B (en) 1997-11-19
    DE69714992D1 (en) 2002-10-02
    PT904234E (en) 2003-01-31
    NO984929D0 (en) 1998-10-22
    NO984929L (en) 1998-12-15

    Similar Documents

    Publication Publication Date Title
    US7527619B2 (en) Medical fluid container
    US7717897B2 (en) Medical fluid container with concave side weld
    EP0554988B1 (en) Mixing apparatus
    AU693835B2 (en) Port adaptor and protector and container having same
    US6179823B1 (en) Multiple use universal connector flexible medical container assembly
    US6308847B1 (en) Medical containers
    US6039718A (en) Multiple use universal connector
    US6241717B1 (en) Single use universal access device/medical container combination
    US5368586A (en) Closure for a drug-vial
    CZ326098A3 (en) Reservoir for parenteral liquids
    EP0904234B1 (en) Improved medical containers
    US20060276769A1 (en) Medical fluid container
    US7115117B2 (en) Infusion vessel
    MX2010008304A (en) Closure cap for containers.
    AU715663C (en) Improved medical containers
    EP1009357B1 (en) Improvements related to medical containers
    AU2007265010B2 (en) Medical fluid container
    WO2016196632A1 (en) Package fitment comprising dual port
    JPH0975425A (en) Medical vessel
    JPH09108302A (en) Medical container and its manufacture
    JPH10328269A (en) Medical container
    JPH07313572A (en) Infusion vessel
    JPH10314273A (en) Medical vessel
    RU2328320C2 (en) Connector of medicinal agent oral set
    JPH0956779A (en) Mouth structure of medical container

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    17P Request for examination filed

    Effective date: 19980930

    AK Designated contracting states

    Kind code of ref document: A1

    Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

    AX Request for extension of the european patent

    Free format text: AL PAYMENT 980930;LT PAYMENT 980930;LV PAYMENT 980930;RO PAYMENT 980930;SI PAYMENT 980930

    17Q First examination report despatched

    Effective date: 19991026

    RAP1 Party data changed (applicant data changed or rights of an application transferred)

    Owner name: FRESENIUS KABI AB

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAA (expected) grant

    Free format text: ORIGINAL CODE: 0009210

    AK Designated contracting states

    Kind code of ref document: B1

    Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

    AX Request for extension of the european patent

    Free format text: AL PAYMENT 19980930;LT PAYMENT 19980930;LV PAYMENT 19980930;RO PAYMENT 19980930;SI PAYMENT 19980930

    REF Corresponds to:

    Ref document number: 222871

    Country of ref document: AT

    Date of ref document: 20020915

    Kind code of ref document: T

    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: FG4D

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: EP

    REF Corresponds to:

    Ref document number: 69714992

    Country of ref document: DE

    Date of ref document: 20021002

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: FG4D

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: NV

    Representative=s name: R. A. EGLI & CO. PATENTANWAELTE

    REG Reference to a national code

    Ref country code: GR

    Ref legal event code: EP

    Ref document number: 20020403325

    Country of ref document: GR

    REG Reference to a national code

    Ref country code: DK

    Ref legal event code: T3

    REG Reference to a national code

    Ref country code: PT

    Ref legal event code: SC4A

    Free format text: AVAILABILITY OF NATIONAL TRANSLATION

    Effective date: 20021127

    ET Fr: translation filed
    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FG2A

    Ref document number: 2183165

    Country of ref document: ES

    Kind code of ref document: T3

    PLBE No opposition filed within time limit

    Free format text: ORIGINAL CODE: 0009261

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

    26N No opposition filed

    Effective date: 20030530

    REG Reference to a national code

    Ref country code: SI

    Ref legal event code: IF

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: DE

    Payment date: 20050624

    Year of fee payment: 9

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: PT

    Payment date: 20060403

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: NL

    Payment date: 20060419

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FR

    Payment date: 20060420

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FI

    Payment date: 20060421

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: SE

    Payment date: 20060424

    Year of fee payment: 10

    Ref country code: MC

    Payment date: 20060424

    Year of fee payment: 10

    Ref country code: LU

    Payment date: 20060424

    Year of fee payment: 10

    Ref country code: AT

    Payment date: 20060424

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: CH

    Payment date: 20060425

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: IE

    Payment date: 20060426

    Year of fee payment: 10

    Ref country code: GB

    Payment date: 20060426

    Year of fee payment: 10

    Ref country code: DK

    Payment date: 20060426

    Year of fee payment: 10

    Ref country code: BE

    Payment date: 20060426

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: GR

    Payment date: 20060428

    Year of fee payment: 10

    Ref country code: ES

    Payment date: 20060428

    Year of fee payment: 10

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: IT

    Payment date: 20060430

    Year of fee payment: 10

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: DE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20061101

    REG Reference to a national code

    Ref country code: PT

    Ref legal event code: MM4A

    Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

    Effective date: 20071023

    REG Reference to a national code

    Ref country code: DK

    Ref legal event code: EBP

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: PL

    GBPC Gb: european patent ceased through non-payment of renewal fee

    Effective date: 20070423

    LTLA Lt: lapse of european patent or patent extension

    Effective date: 20070423

    BERE Be: lapsed

    Owner name: *FRESENIUS KABI A.B.

    Effective date: 20070430

    NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

    Effective date: 20071101

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: PT

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20071023

    Ref country code: NL

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20071101

    Ref country code: MC

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070430

    Ref country code: FI

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070423

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: MM4A

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: AT

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070423

    Ref country code: CH

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070430

    Ref country code: LI

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070430

    REG Reference to a national code

    Ref country code: SI

    Ref legal event code: KO00

    Effective date: 20071205

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: BE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070430

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GB

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070423

    Ref country code: DK

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070430

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: IE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070423

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: SE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070424

    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FD2A

    Effective date: 20070424

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: FR

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070430

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GR

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20071102

    Ref country code: ES

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070424

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: LU

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070423

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: IT

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20070423